<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="67317">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02229487</url>
  </required_header>
  <id_info>
    <org_study_id>08-57-16</org_study_id>
    <nct_id>NCT02229487</nct_id>
  </id_info>
  <brief_title>The Relationship Between Sleep and Glucose Tolerance in Prediabetes: the Role of GLP-1 in Short Sleepers</brief_title>
  <acronym>Sleep GLP-1</acronym>
  <official_title>The Relationship Between Sleep and Glucose Tolerance in Prediabetes: the Role of GLP-1 in Short Sleepers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ramathibodi Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Merck Sharp &amp; Dohme Corp.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Ramathibodi Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Hypothesis

        1. Prediabetes patients who have insufficient sleep will have worse glucose tolerance than
           those with normal sleep duration.

        2. Prediabetes patients with short sleep will have a delayed or reduced GLP-1 response to
           a standardized meal
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2014</start_date>
  <primary_completion_date type="Anticipated">February 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>No masking</masking>
  </study_design_info>
  <primary_outcome>
    <measure>GLP-1 levels in response to oral glucose tolerance test</measure>
    <time_frame>2 weeks</time_frame>
    <description>Prediabetes patients with and without short sleep will undergo an oral glucose tolerance test with measurement of GLP-1 levels</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Prediabetes</condition>
  <arm_group>
    <arm_group_label>Normal Sleepers</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Prediabetes patients with normal sleep duration (7-8 hours/ night) as measured objectively</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Short Sleepers</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Prediabetes patients with short sleep duration (&lt;6 hours/night) as measured objectively</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Oral glucose tolerance</intervention_name>
    <arm_group_label>Normal Sleepers</arm_group_label>
    <arm_group_label>Short Sleepers</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patients with prediabetes (HbA1c 5.7-6.4% or history of fasting plasma glucose
             100-125 mg/dl) who receive medical care at Ramathibodi Hospital

          2. Age 18 or older

          3. Can understand Thai (speaking, listening and reading)

          4. Agree to participate by written informed consent

        Exclusion Criteria:

          1. Those who depend on others for feeding (such as stroke patients)

          2. Shift workers

          3. History of congestive heart failure or low ejection fraction

          4. Chronic obstructive pulmonary disease, end stage renal disease or chronic liver
             disease (AST or ALT &gt; 3 times the upper limit of normal)

          5. Use of medications: opioids/ narcotics , alpha blockers (prazosin, doxazosin,
             terazosin), clonidine, methyldopa, nitroglycerin

          6. Patients with permanent pacemaker

          7. History of previous stroke
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Sirimon Reutrakul, MD</last_name>
    <phone>662-2011643</phone>
    <email>sreutrak10800@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Faculty of Medicine Ramathibodi Hospital</name>
      <address>
        <city>Bangkok</city>
        <country>Thailand</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sirimon Reutrakul, MD</last_name>
      <email>sreutrak10800@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Sirimon Reutrakul, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <verification_date>February 2017</verification_date>
  <lastchanged_date>February 28, 2017</lastchanged_date>
  <firstreceived_date>August 28, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ramathibodi Hospital</investigator_affiliation>
    <investigator_full_name>Sirimon Reutrakul</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>Prediabetes</keyword>
  <keyword>Short sleepers</keyword>
  <keyword>GLP-1</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Prediabetic State</mesh_term>
    <mesh_term>Glucose Intolerance</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
